2-10722939-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001039362.2(ATP6V1C2):c.90C>A(p.Asn30Lys) variant causes a missense change. The variant allele was found at a frequency of 0.00106 in 1,614,064 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00065 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0011 ( 1 hom. )
Consequence
ATP6V1C2
NM_001039362.2 missense
NM_001039362.2 missense
Scores
6
13
Clinical Significance
Conservation
PhyloP100: 3.83
Genes affected
ATP6V1C2 (HGNC:18264): (ATPase H+ transporting V1 subunit C2) This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A,three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site. This gene encodes alternate transcriptional splice variants, encoding different V1 domain C subunit isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.025514722).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6V1C2 | NM_001039362.2 | c.90C>A | p.Asn30Lys | missense_variant | 2/14 | ENST00000272238.9 | NP_001034451.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP6V1C2 | ENST00000272238.9 | c.90C>A | p.Asn30Lys | missense_variant | 2/14 | 5 | NM_001039362.2 | ENSP00000272238.4 | ||
ATP6V1C2 | ENST00000635370.1 | c.90C>A | p.Asn30Lys | missense_variant | 1/14 | 5 | ENSP00000489280.1 | |||
ATP6V1C2 | ENST00000381661.3 | c.90C>A | p.Asn30Lys | missense_variant | 2/13 | 2 | ENSP00000371077.3 | |||
ATP6V1C2 | ENST00000648362.1 | c.90C>A | p.Asn30Lys | missense_variant | 2/12 | ENSP00000497038.1 |
Frequencies
GnomAD3 genomes AF: 0.000651 AC: 99AN: 152096Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
99
AN:
152096
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000597 AC: 150AN: 251428Hom.: 1 AF XY: 0.000552 AC XY: 75AN XY: 135882
GnomAD3 exomes
AF:
AC:
150
AN:
251428
Hom.:
AF XY:
AC XY:
75
AN XY:
135882
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00110 AC: 1607AN: 1461850Hom.: 1 Cov.: 31 AF XY: 0.00104 AC XY: 759AN XY: 727222
GnomAD4 exome
AF:
AC:
1607
AN:
1461850
Hom.:
Cov.:
31
AF XY:
AC XY:
759
AN XY:
727222
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000650 AC: 99AN: 152214Hom.: 0 Cov.: 31 AF XY: 0.000564 AC XY: 42AN XY: 74426
GnomAD4 genome
AF:
AC:
99
AN:
152214
Hom.:
Cov.:
31
AF XY:
AC XY:
42
AN XY:
74426
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
3
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
10
ExAC
AF:
AC:
72
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 17, 2023 | The c.90C>A (p.N30K) alteration is located in exon 2 (coding exon 1) of the ATP6V1C2 gene. This alteration results from a C to A substitution at nucleotide position 90, causing the asparagine (N) at amino acid position 30 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;L;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;D;.
REVEL
Benign
Sift
Benign
.;T;T;.
Sift4G
Benign
.;T;T;T
Polyphen
0.46, 0.93
.;P;P;.
Vest4
0.56, 0.54, 0.56
MutPred
Loss of ubiquitination at K28 (P = 0.0162);Loss of ubiquitination at K28 (P = 0.0162);Loss of ubiquitination at K28 (P = 0.0162);Loss of ubiquitination at K28 (P = 0.0162);
MVP
0.50
MPC
0.29
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at